Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Psoriatic 1

Interventions

sonelokimab 1 risankizumab 1 cabozantinib 1 Standard of Care 1 Specimen Handling 1 Practice Guidelines as Topic 1 Platinum Compounds 1 Nivolumab 1 Methods 1 Ipilimumab 1 Interviews as Topic 1 Educational Status 1 Early Intervention, Educational 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Arthritis, Psoriatic × risankizumab × Clear all

NCT06641089 2026-05-18

IZAR-2

MoonLake Immunotherapeutics AG

Phase 3 Recruiting

Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡